Mineralys Therapeutics, Inc. · NASDAQ:MLYS
Rodman David Malcom sold 416 Mineralys Therapeutics, Inc. shares (Form 4)
Traded Jul 17, 2026 · Filed Jul 20, 2026
On Jul 17, 2026, Rodman David Malcom (Chief Medical Officer) sold 416 Mineralys Therapeutics, Inc. shares at US$26.53 for US$11,036 under a trading plan, leaving 51,384 shares. Filed Jul 20, 2026 (Form 4).
- Sold
- 416 shares
- Price
- US$26.53
- Value
- US$11,036
- Holding after
- 51,384 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Chief Medical Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jul 17, 2026 | Common Stock | Option exercise | 416 | US$15.44 | 51,800 | Direct |
| Jul 17, 2026 | Common Stock | Sale | 416 | US$26.53 | 51,384 | Direct |
Source
Related
- Mineralys Therapeutics, Inc.
- Rodman David Malcom
- Mineralys Therapeutics, Inc. shareholders
- Form 4 · Rodman David Malcom · Aug 12, 2026
- Form 4 · Rodman David Malcom · Jul 15, 2026
- Form 4 · Rodman David Malcom · Jul 10, 2026
- Form 4 · Rodman David Malcom · Jun 17, 2026
- Form 4 · Rodman David Malcom · Jun 12, 2026
- Form 4 · Peterson Kristine · Oct 20, 2026
- Form 4 · Coats Lonnel · Oct 20, 2026
- Form 4 · Congleton Jon · Oct 2, 2026
- Form 4 · Slingsby Brian Taylor · Sep 24, 2026
- Form 4 · Warren Eric · Sep 22, 2026